Partial Lipodystrophy clinical trials

Explore recruiting partial lipodystrophy clinical trials.

Recruiting partial lipodystrophy studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Partial Lipodystrophy trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A 24-Month, Multi-Centre, Open Label Phase IV Post Authorisation Efficacy Study to Evaluate the Efficacy, Safety and Immunogenicity of Daily Subcutaneous Metreleptin Treatment in Patients with Partial Lipodystrophy

Italy, Germany, France

Therapeutic use (Phase IV) EU CTIS Study details

A 12-Month Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase 3 Study to Evaluate the Safety and Efficacy of Daily Subcutaneous Metreleptin Treatment in Subjects with Partial Lipodystrophy

Spain, Netherlands, Belgium, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Partial Lipodystrophy trials by city

Partial Lipodystrophy in Toronto Partial Lipodystrophy in Vancouver Partial Lipodystrophy in Montreal Partial Lipodystrophy in Calgary Partial Lipodystrophy in Edmonton Partial Lipodystrophy in Ottawa Partial Lipodystrophy in Winnipeg Partial Lipodystrophy in Quebec City Partial Lipodystrophy in Hamilton Partial Lipodystrophy in Kitchener Partial Lipodystrophy in London Partial Lipodystrophy in Halifax Partial Lipodystrophy in New York Partial Lipodystrophy in Los Angeles Partial Lipodystrophy in Chicago Partial Lipodystrophy in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease